Clinical Trials Logo

Clinical Trial Summary

Adenovirus conjunctivitis is an epidemic disease registered as a common occupational disease for ophthalmologists and orthoptists. It can leave corneal sequelae even several years after infection.

The primary aim of the study is to investigate the prevalence of these sequelae in the at-risk population of ophthalmologists and orthoptist.

Secondary aim are to describe administrative procedures (occupational disease declaration and sick leave),infections characteristics; and risk factors.


Clinical Trial Description

Adenovirus conjunctivitis is an epidemic disease registered as a common occupational disease for ophthalmologists and orthoptists. It can leave corneal sequelae even several years after infection.

The investigation tream create a nationwide anonymous retrospective questionnaire using the secure internet application REDCap® to build and manage the questionnaire addressed to ophtalmologists (interns, graduates and retirees) and orthoptists.

Investigator collect several characteristics such as general characteristics (sex, age range, profession), administrative procedure declaration (occupational disease declaration, sick leave, cessation of surgery); infection characteristics (bilaterality, season, anteriority, sequels, current therapy, professional discomfort), risk factor (refractive surgery history, wearing of eyeglasses or contact lenses, smoking, or corticosteroid therapy).

The primary aim of the study is to investigate the prevalence of these sequelae in the at-risk population of ophthalmologists and orthoptist. Secondary aim are to describe administrative procedures (occupational disease declaration and sick leave), infections characteristics; and risk factors such as a refractive surgery history, the wearing of eyeglasses or contact lenses, smoking, or corticosteroid therapy. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04417244
Study type Observational
Source University Hospital, Clermont-Ferrand
Contact Lise Laclautre
Phone 0473754963
Email pormo_interne_drci@chu-clermontferrand.fr
Status Recruiting
Phase
Start date October 21, 2019
Completion date October 2022

See also
  Status Clinical Trial Phase
Active, not recruiting NCT05123014 - Lenticule Implantation and Autologous Serum New Approach in Treatment of Adenoviral Keratitis Disease N/A
Not yet recruiting NCT04041856 - Povidone-iodine 2% Eye Drop Versus Artificial Tear Drop for Treatment of Adenoviral Keratoconjunctivitis Phase 1/Phase 2
Completed NCT04376970 - Treatment of Corneal Infiltrates Secondary to Epidemic Keratoconjunctivitis Phase 4